SCO 5-6, Zirakpur-Panchkula-Kalka Hwy, near Hotel Sunpark, Wadhawa Nagar, Dhakoli, Zirakpur, Punjab 140603

Glimipride Me ormin(SR) Voglibose Tablet

Glimipride Me ormin(SR) Voglibose Tablet - Manufacturers & Suppliers - Third Party Contract Manufacturing - PCD Pharma Franchise

Glimipride Me ormin(SR) Voglibose Tablet

Composition : CORAVOG-GM1

Packing : 10x10

Price : Rs. 885

Please Contact Us

Metformin Hydrochloride (SR) Glimepiride & Voglibose Tablets is a combination of three effective antidiabetic medicines: Glimepiride, Metformin, and Voglibose. They all have a different working mechanism to provide better control of blood sugar when single or dual therapy is not effective.

Working Mechanism of Glimepiride, Metformin, and Voglibose:-

Glimepiride is a sulfonylurea that lowers blood glucose by increasing the amount of insulin released by the pancreas. Metformin is a biguanide that reduces glucose synthesis in the liver, slows glucose absorption in the intestines, and improves insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that stops complex carbohydrates from being broken down into simple sugars like glucose. After meals, blood glucose levels do not rise to dangerously high levels as a result of this.

To avoid having an upset stomach, take this medicine with food. This medicine's dose and duration are determined by the patient's medical history and tolerance. It can cause hypoglycemia (low blood sugar level) if you use it with other anti-diabetic medications or if you skip or delay a meal. For instant relief, keep a sugar supply with you at all times.

Due to sustained release formulation, Metformin Hydrochloride (SR) Glimepiride & Voglibose Tablets must be swallowed whole and not crushed, or, chewed.

DURING PREGNANCY

Metformin Hydrochloride (SR) Glimepiride & Voglibose Tablets must not be taken during pregnancy. Otherwise, there is a risk of harm to the child. The patient must change over to insulin during pregnancy.

IF LACTATING

To prevent possible ingestion of breast milk and possible harm to the child, Metformin Hydrochloride (SR) Glimepiride & Voglibose Tablets must not be taken by breast-feeding women. If necessary the patient must change over to insulin or must stop breastfeeding.

DRIVING A VEHICLE OR PERFORMING OTHER HAZARDOUS TASKS

Alertness and reactions may be impaired due to hypo- or hyperglycemia, especially when beginning or after altering a treatment or when Metformin Hydrochloride (SR) Glimepiride & Voglibose Tablets is not taken regularly. This may, for example, affect the ability to drive or to operate machinery.

ADVERSE REACTIONS

Metformin Hydrochloride (SR) Glimepiride & Voglibose Tablets should be administered carefully in patients who are receiving other antidiabetic drugs because hypoglycemia may occur.

FAQ’s

Q. What is Glimepiride+Metformin+Voglibose?

A. Glimepiride+Metformin+Voglibose is a combination of three medicines: Glimepiride, Metformin, and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves the blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers blood glucose levels by increasing the release of insulin from the pancreas. Metformin works by lowering glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers the postprandial (after meals) glucose levels in the body. This combination is not indicated for the treatment of Type 1 DM.

Q. What are the possible side effects of Glimepiride+Metformin+Voglibose?

A. The use of Glimepiride+Metformin+Voglibose is associated with common side effects like hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.

Q. Are there any specific conditions in which Glimepiride+Metformin+Voglibose should not be taken?

A. The use of Glimepiride+Metformin+Voglibose should be avoided in patients with known allergies to any of the components or excipients of this medicine. The use of this medicine is also avoided in patients with moderate to severe kidney disease and in patients with inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.

Q. Is it safe to take alcohol while I am also taking Glimepiride+Metformin+Voglibose?

A. No, it is not safe to take Glimepiride+Metformin+Voglibose along with alcohol. It may lower your low blood sugar levels (hypoglycemia) and can increase the chances of lactic acidosis.

Q. Can the use of Glimepiride+Metformin+Voglibose cause hypoglycemia?

A. Yes, the use of Glimepiride+Metformin+Voglibose can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It happens more often if you miss or delay your food, drink alcohol, over-exercise, or take other antidiabetic medicine along with it. So, regular monitoring of blood sugar levels is important. Always keep glucose tablets, honey, or fruit juice with you.

Q. What are the instructions for the storage and disposal of Glimepiride+Metformin+Voglibose?

A. Keep this medicine in the packet or the container it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children, and other people.